Karen Sweiss

15PUBLICATIONS
35CO-AUTHORS
Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyPharmacogenomicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 11, 2025
Persistent opioid use is associated with a shorter myeloma survival.

Karen Sweiss, Ana Maria Avila Rodriguez, John G Quigley

|Nov 09, 2023
Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies.

Nadia A Nabulsi, Lisa K Sharp, Karen I Sweiss

|Jan 15, 2021
Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare.

Jifang Zhou, Karen Sweiss, Edith A Nutescu

|Jun 05, 2020
Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan.

Karen Sweiss, Gregory Sampang Calip, Jaime Holden

Pageof 3